首页> 外文会议>Pacific Rim International Conference on Advanced Materials and Processing >Particle Size Reduction of Biomaterials Using Cryogenic Milling Process
【24h】

Particle Size Reduction of Biomaterials Using Cryogenic Milling Process

机译:使用低温研磨过程减少生物材料的粒度

获取原文

摘要

Reducing the particle size of drug materials down to submicron is an important matter in pharmaceutical industry. Cryogenic milling technology is one of the mechanical milling processes, which is mostly utilized in refining grain size of metal and ceramics at extremely low temperature environment. This technique has not been readily studied in application to medical and biotechnology. This paper, therefore, describes the application of cryogenic milling process to reduce particle size of Ibuprofen. The shape and size of the Ibuprofen particle before and after the cryogenic ball milling process were analyzed. XRD analysis was performed to examine a change in crystallinity of Ibuprofen by the cryogenic ball milling process. The results showed that the size of Ibuprofen particles was reduced to 1/10 or less of its initial size. The results also showed that the degree of crystallinity of Ibuprofen was slightly reduced after cryogenic ball milling with nitrogen.
机译:将药物材料的粒径降低到亚微米是制药行业的重要事项。 低温研磨技术是机械研磨过程之一,主要用于在极低温度环境下精炼金属和陶瓷的晶粒尺寸。 在医学和生物技术应用中尚未容易地研究该技术。 因此,本文描述了低温研磨过程的应用,从而降低布洛芬的粒径。 分析了低温球铣削过程之前和之后的布洛芬颗粒的形状和尺寸。 进行XRD分析以检测冷冻球铣削过程中布洛芬结晶度的变化。 结果表明,其初始尺寸的布洛芬颗粒的尺寸降低至1/10或更小。 结果还表明,在低温球铣削后,布洛芬的结晶度略微减少了氮气。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号